Decoding pH‐Driven Phase Transition of Lipid Nanoparticles
Researchers applied constant‑pH molecular dynamics to the Comirnaty lipid nanoparticle formulation, uncovering a dramatic pKa shift for the ionizable aminolipid ALC‑0315. The intrinsic pKa of 9.3 in water drops to an apparent 4.9 within the LNP, with surface regions remaining protonated at low pH and the core deprotonated near neutral pH. This pH‑dependent reorganization drives efficient mRNA encapsulation and structural stabilization, revealing how lipid environment controls nanoparticle phase transitions. The findings offer molecular guidance for designing next‑generation lipid carriers.
Studying Tumor Stem Cell Role in Oral Cancer
Researchers at the National Cancer Institute have uncovered a pivotal role for tumor stem cells in oral squamous cell carcinoma, linking a specific CD44+ subpopulation to aggressive disease and treatment resistance. Using single‑cell RNA sequencing, the team identified novel stemness...
Identity Management Challenges in Pharma & Biotech SaaS Platforms (And How to Solve Them)
Pharma and biotech firms are accelerating SaaS adoption for drug discovery, clinical trials, and manufacturing, but fragmented identity and access management (IAM) threatens compliance and intellectual‑property protection. The life‑sciences software market hit $16.1 billion in 2024 and is growing 11‑13% annually,...
JPM Movers: ImmunityBio Rises to the Top
ImmunityBio announced a first‑in‑human readout of its off‑the‑shelf CD19 t‑haNK CAR‑NK therapy combined with rituximab, delivering a durable 15‑month complete response in four Waldenstrom lymphoma patients. The data propelled the stock to $5.52, up 137% from the prior week and added...
Stem Cell Gym Boosts Human Heart Cell Maturation
A new micro‑engineered platform dubbed the Stem Cell Gym has been shown to accelerate the maturation of human induced pluripotent stem cell‑derived cardiomyocytes. Researchers reported a 30‑40% increase in electrophysiological and contractile markers compared with conventional culture methods. The system...
Mitochondrial Transfer: Dual Impact on Health and Disease
Mitochondrial transfer, the movement of energy‑producing organelles between cells, is gaining prominence as a dual‑edged biological process. Healthy mitochondria can rescue stressed or damaged cells, offering therapeutic promise for neurodegenerative and cardiac diseases. Conversely, tumor cells may hijack this mechanism...
Inflammation Speeds DNA Methylation Aging, Impairing Cognition
Systemic inflammation is associated with cognitive impairment. New paper suggests this relationship is caused by an acceleration of DNA methylation age https://www.tandfonline.com/doi/full/10.1080/17501911.2025.2595905
Sequencing Boom Drives Quantity over Quality in Biology Publishing
Anyone else feel that since next-gen sequencing and bioinformatics, publishing a paper in biology has become increasingly about quantity than quality?
Korea’s Ildong Promotes Chae Joon Lee to Co-CEO
Ildong Pharmaceutical promoted Chae Joon Lee from COO to co‑CEO while retaining his president role, and he will continue overseeing affiliates such as Yunovia, ILeadBMS, and Idience. The move signals a leadership reshuffle aimed at integrating operational expertise with strategic...
New Genetic Insights Into Strobilanthes Cusia Cultivation
Researchers have sequenced the genome of Strobilanthes cusia and identified key genes governing indigo pigment production and stress tolerance. The study reveals specific transcription factors that boost alkaloid biosynthesis and pinpoint markers for high‑yield cultivars. Field trials using marker‑assisted selection...
Agomab and SpyGlass File for IPOs as Investor Enthusiasm Builds After JPM
SpyGlass Pharma and Agomab Therapeutics announced filings for initial public offerings on Friday, signaling a new wave of biotech listings. Both companies aim to capitalize on heightened investor enthusiasm sparked by JPMorgan's recent focus on life‑science investments. SpyGlass plans to...
More Cash Flows Into Biotechs During Conference Week: Finance Report
During the J.P. Morgan Healthcare Conference, biotech companies attracted roughly $950 million in new capital, spread across 19 mostly private firms. The influx followed an early‑2026 surge of venture deals that pushed total private biotech funding to about $3 billion. Most of...
AbbVie, Genmab Say Epkinly Didn't Prolong Overall Survival in Lymphoma Study
AbbVie and Genmab announced that their antibody‑drug conjugate Epkinly failed to extend overall survival in a Phase 3 trial for diffuse large B‑cell lymphoma (DLBCL). The study, which compared Epkinly plus standard chemotherapy against chemotherapy alone, showed no statistically significant OS...
Antioxidant Effects of Decolorized Rosemary in Pork
Researchers evaluated decolorized rosemary extract as a natural antioxidant for pork, demonstrating a 30% reduction in lipid oxidation and extending refrigerated shelf life by up to five days. The decolorization process removed the herb’s green color and strong flavor, preserving...
Drugmakers without MFN Pacts Are Bracing to Make One
Last year President Donald Trump urged almost all U.S. drugmakers to slash prices, but only 17 companies complied with a direct demand. The majority of manufacturers resisted, avoiding formal most‑favored‑nation (MFN) pricing agreements. Industry analysts now warn that, facing renewed...
Most Pediatric Flu Deaths Unvaccinated as Toll Rises
1. Time for a #flu update. 🧵 #CDC was informed of 15 more pediatric flu deaths in the week ending 1/10, which brings this season's total to date to 32. This number, sadly, will continue to climb because kids & teens...
Tiny Nanocourier that Delivers Molecular Packages to Cell Surface Unveiled
An international team led by Pompeu Fabra University scientists visualized the nanomachine that drives constitutive exocytosis, naming it ExHOS – a flexible ring formed by seven exocyst protein assemblies. Using combined advanced light, electron microscopy and AI‑driven image analysis, they...
Upcoming US Clinical Trial to Test a Tiny Eye Implant that Could Restore Sight for Age-Related Macular Degeneration (AMD)
USC’s Roski Eye Institute, together with Regenerative Patch Technologies, is launching a phase 2b, multicenter, masked clinical trial of a stem‑cell‑derived retinal pigment epithelium (RPE) implant for advanced dry age‑related macular degeneration (AMD). The ultra‑thin patch, derived from embryonic stem...
Makary Talks FDA's Plans to Combat China's Biotech Growth
FDA Commissioner Marty Makary announced that the agency is overhauling its Phase 1 clinical‑trial framework to address the rapid influx of Chinese biotech firms into the U.S. market. The revision will tighten data‑integrity standards, boost early‑phase safety monitoring, and create clearer...
The Impact of Patient-Centric Formulations on Service Providers
Patient‑centric drug development is reshaping the pharmaceutical landscape, prompting sponsors to turn to CDMOs for specialized formulation services. Advanced modalities such as peptides and RNA therapies have heightened formulation complexity, driving a surge in outsourcing to CDMOs with AI‑enabled platforms...
Enhancing Nursing Students’ Genetics Experience Through Leadership
A new initiative at several nursing schools uses leadership-driven curricula to deepen genetics education for nursing students. Faculty mentors guide students through hands‑on genomic case studies, simulation labs, and interdisciplinary projects. Early assessments show a 22% rise in genetics competency...
Top JPM26 Highlights: Weekly BioTech Recap
Here is my favourite weekly 🧵- made by my dear friend @BiopharmIQ, which is a comprehensive recap of the past week in BioTech. This time he gathered the best posts - written by some of the brightest BioX accounts, about...
MCM8 Accelerates Colorectal Cancer by Inhibiting Ubiquitination
A recent study reveals that the DNA helicase MCM8 is markedly overexpressed in colorectal cancer and drives tumor progression by blocking ubiquitination pathways. By preventing the degradation of oncogenic substrates, MCM8 stabilizes proteins that promote cell proliferation and metastasis. The...
Longevity Demands Whole‑Life Habits, Not One Simple Fix
I’m often asked what the one thing to increase longevity. If it were that simple, many more people would already live to 100 Here are some tips: 1. Avoid sugar, simple carbs, alcohol 2. Lose your breath for 10 min 3x/week...
Tylenol Use in Pregnancy Shows No Increased Neurodevelopmental Risks
Tylenol during pregnancy is safe without increased risk of autism, ADHD, or intellectual disability of offspring A new review of the evidence just out https://t.co/Kjwp1h3PBP
Delgocitinib
In July 2025, the FDA granted approval to delgocitinib (Anzupgo®), a topical pan‑JAK inhibitor, for adult chronic hand eczema unresponsive or unsuitable for corticosteroids. Developed by Japan Tobacco and Leo Pharma, the formulation delivers the drug directly to affected skin,...
Cheap Generic Antibiotics Deliver Massive Healthcare Savings
Correct. This is why we should push more of healthcare towards medicine. By far the highest leverage technology in healthcare. Consider the $5 generic antibiotic you take that saves a hospital stay. Insane savings.
Autonomous Microsurgical Robot Delivers Precise Retinal Injections
Scientists have developed a #microsurgical robot that can perform #autonomous and precise retinal injections in animal models. Learn more in Science #Robotics: https://t.co/EdjxTYp5lA https://t.co/WrUZgKjYOT
PharmTech Weekly News Roundup – Week of January 12, 2026
The PharmTech Weekly roundup underscores a rapid shift toward agentic AI, sustainability, and resilient supply chains across drug development. The FDA and EMA released ten guiding principles for ethical AI use, while companies like Dycem, Jubilant Biosys, and SÜDPACK highlighted...
Scientists Transform Enigmatic Cell Structures Into Devices for Recording RNA Activity
Researchers have engineered the naturally occurring vault particle into a synthetic "TimeVault" that sequesters mRNA inside the ribonucleoprotein shell, protecting it from degradation for more than a week. By fusing a major‑vault‑protein binding domain with an mRNA‑binding motif, the system...
New SLAC Method Guides Better Cell Slice Preparation for Cryo-ET Imaging
SLAC National Accelerator Laboratory researchers have introduced a tri‑coincident system that synchronizes a scanning electron microscope, an ion‑beam mill, and an optical microscope to guide cryogenic electron tomography (cryo‑ET) sample preparation. By exploiting interference patterns in fluorescent light emitted from...
Super Agers Show APOE‑ε4 Reduction, Like Healthy Controls
Super Agers with intact cognitive function and the frequency of the APOE-ε4 and APOE-ε2 alleles compared with controls and people with Alzheimer’s disease https://t.co/vMYcSTVCDS
Vedanta ‘Significantly’ Reduces Staff, Focuses on Phase III Study of C. Diff Drug
Vedanta Biosciences announced a major headcount reduction, cutting roughly half of its workforce to preserve cash for a Phase III trial of its oral C. difficile candidate VE303. The layoffs follow earlier cuts after a failed Phase II study of VE202 and reflect...
Intentional GenAI Use Can Reduce Global Health Inequities
GenAI has the potential to worsen health inequities. In a new review @NatureHealthJnl we show that with intent, confronting the challenges, it could be just the opposite, globally @nliulab https://t.co/jwmslSVIV1 https://t.co/5q3gq9mnez
BiotechCH's Space: Must‑Watch for BioTech & Pharma Enthusiasts
I highly recommend attending @BiotechCH’s upcoming space today - which in my opinion is the most interesting space on 𝕏 for those interested in BioTech, Pharma, Life Sciences & everything in between….If you can’t attend it’s also available on the...
Microglial FcγR Drives Dopaminergic Neuron Loss
A new study reveals that microglial Fcγ receptors (FcγR) actively drive the loss of dopaminergic neurons, a hallmark of Parkinson's disease. Researchers demonstrated that FcγR activation triggers inflammatory cascades that exacerbate neuronal death in both mouse models and human post‑mortem...
ImmunityBio's Cell Therapy Posts Encouraging Early Data in Rare Blood Cancer
ImmunityBio reported encouraging early data from its off‑the‑shelf cell‑therapy platform in a Phase 1 trial (QUILT) targeting a rare form of lymphoma. The small study demonstrated a favorable safety profile and preliminary efficacy signals, including objective responses in several patients. The...
Is AstraZeneca’s Surovatamig Underappreciated?
AstraZeneca’s head of Oncology Commercial labeled its early‑stage candidate surovatamig ‘underappreciated’ during the J.P. Morgan Healthcare conference, prompting analysts to reassess the drug’s market potential. The comment followed the presentation of phase 1 data at the American Society of Hematology meeting, where...
Regulate DNA Fragments to Bypass Synthesis Screening
A proposed regulatory framework would allow short synthetic DNA fragments to bypass mandatory synthesis screening, aiming to streamline research and reduce costs. The draft sets a length threshold—typically 200 base pairs—and requires labs to register exempted fragments with a central...
Medications for Opioid Use Disorder: Overcoming Integration Barriers
Researchers Desai et al. identify persistent barriers that prevent medication‑assisted treatment (MAT) for opioid use disorder from being fully integrated into specialty programs. Stigma toward patients and providers, restrictive regulations, and insufficient clinician training limit the use of proven drugs such...
UC San Diego Launches ARPA-H Project to 3D Bioprint Patient-Specific Human Livers
UC San Diego, backed by a $25.8 million ARPA‑H grant, is developing a 3‑D bioprinting platform to create patient‑specific, functional human livers. The multidisciplinary team combines rapid light‑based printing with AI‑driven vascular design to fabricate complex, multi‑cellular tissue in seconds. Partnering...
JPM26: Protagonist Has a $400M Decision To Make. It’s a No-Brainer
Protagonist Therapeutics faces a pivotal choice on its rusfertide partnership with Takeda. The company is leaning toward opting out of the 50‑50 co‑development deal, which would trigger a $400 million opt‑out payment and tiered royalties up to 29% on sales exceeding...
Ensuring the Supply Chain Through Purchasing Controls
Establishing a secure supply chain now starts with early, cross‑functional purchasing controls. Development, quality, and procurement teams must collaborate to define requirements, qualify suppliers, and create quality agreements before scale‑up. The Parenteral Drug Association’s upcoming ANSI/PDA Standard 001‑2020 formalizes these expectations...
SÜDPACK Medica to Unveil Next-Generation Sustainable Packaging and Streamlined Services at Pharmapack Europe 2026
At Pharmapack Europe 2026, SÜDPACK Medica introduced its next‑generation PharmaGuard blister line, a mono‑material polypropylene solution that replaces multi‑layer composites with a recyclable, phthalate‑free film, now available in an opaque white version for better dosage readability. The company also launched...
Lynch Syndrome Vaccine Shows Strong Immune Response, Safety
A vaccine to prevent colon cancer. Proof-of-concept for strong immune response and safety via neoantigens given to people with mutations for Lynch syndrome https://t.co/EfXDlTJlIz https://t.co/RtxfB4oGZ1
Longevity Gene Claim Debunked: Study Proves Wrong
1/ A 2010 Science paper claimed they'd found genetic variants strongly tied to living past 100. New York Times covered it. Media went wild. One problem: The results were wrong.
#JPM26: Sandoz CEO on Ozempic Generic Launch Plans for 2026
Sandoz, Novartis' generics arm, announced plans to launch a generic version of Ozempic (semaglutide) in 2026. The move aligns with the anticipated expiration of Novo Nordisk's patents on the GLP‑1 drug, opening the U.S. and European markets to lower‑priced alternatives....
Wegovy Pill Shows Strong Early Uptake, as Rival Looms
Novo Nordisk's oral Wegovy pill recorded 3,071 prescriptions within its first four days on the U.S. market, a figure that excludes sales through its NovoCare direct‑to‑consumer channel. The launch arrives as Eli Lilly awaits an FDA decision on its own oral...
JPM 2026: What’s the Outlook Like This Year?
The J.P. Morgan Healthcare Summit in San Francisco highlighted a surge in radiopharmaceutical development, positioning precision radiation therapy as a key growth area in oncology. AI‑driven molecular profiling is accelerating biomarker discovery and drug design, while the GLP‑1 market expands with...